FOR IMMEDIATE RELEASE
January 5, 2022
New Docs Reveal Department of Defense Controlled COVID-19 Program from the Start
FDA Vaccine Approval Process was Theater
A combinationofthePREP Act, Emergency Use Authorization, and Other Transactions Authority (OTA) Shielded Big Pharma, Agencies,and Medical Participants that Delivered Unregulated Vaccines from Any Liability
WASHINGTON, DC -According to congressionally passed statutes, research of active laws,and extra details obtained through the Freedom of Information Act, the Department of Defense owns, implements, and oversees the COVID-19 vaccine program as a“Countermeasure” to foreign attack.While the public was bombarded with an orchestrated fear campaign,the U.S.Government managed the Covid response as a national security threat.
The Three-Legged Stool
The undercover operation was orchestrated utilizing three critical legal maneuvers:
1. Emergency Use Authorization EUA.
2. Prep Act,
3. Other Transactions Authority
President Trump declared a Public Health Emergency (PHE) on March 13, 2020, under the Stafford Act, putting the National Security Council in charge of the Covid policy.Covid-19 vaccines are “medical countermeasures” – a grey area of products that are not regulated as vaccines or medicines.
“They put the National Security Council in charge and treated it as an act of war,” said Latypova.
According to Operation Warp Speed/ASPR reports, the DoD ordered, oversaw, and tightly managed the development, manufacture, and distribution of Covid countermeasures,mainly utilizing the DoD’s previously established network of military contractors and consortia.
Department of Defense, BARDA, and HHS ordered all Covid countermeasures, including “vaccines” as prototype demonstrations of large-scale manufacturing, avoiding regulations and transparency under Other Transaction Authority. As prototypes used under EUA during PHE, Covid countermeasures, including “vaccines,” need not comply with the U.S. laws for manufacturing quality, safety, and labeling.
“The implication is that theU.S.Government authorized and funded the deployment of noncompliant biological materials on Americans without clarifying their “prototype” legal status, making the materials not subject to normal regulatory oversight, all while maintaining a fraudulent pseudo- “regulatory” presentation to the public,” said Latypova.
“Most incredible is the fact that current Laws enacted by the United States Congress appear to make the coverup actions LEGAL
Read More HERE